INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.085
+0.175 (9.16%)
At close: Aug 7, 2026, 4:00 PM EDT
2.021
-0.064 (-3.08%)
After-hours: Aug 7, 2026, 7:34 PM EDT
INmune Bio Employees
INmune Bio had 21 employees as of December 31, 2025. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
n/a
Profits / Employee
-$876,952
Market Cap
55.43M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -1 | -4.55% | 21 | 0 |
| Dec 31, 2024 | 22 | 5 | 29.41% | 13 | 9 |
| Dec 31, 2023 | 17 | 7 | 70.00% | 11 | 6 |
| Dec 31, 2022 | 10 | 0 | - | 10 | 0 |
| Dec 31, 2021 | 10 | 5 | 100.00% | 10 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 139 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Mereo BioPharma Group | 39 |
| eXoZymes | 32 |
| RenovoRx | 17 |
| Instil Bio | 17 |
| Context Therapeutics | 15 |
INMB News
- 2 days ago - INmune Bio Earnings Call Transcript: Q2 2026 - Transcripts
- 2 days ago - INmune Bio Quarterly report: Q2 2026 - Filings
- 2 days ago - INmune Bio Earnings release: Q2 2026 - Filings
- 8 days ago - INmune Bio receives $4.6M in rebates from Australia, UK - TheFly
- 8 days ago - INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th - GlobeNewsWire
- 8 days ago - INmune Bio Receives R&D Rebates of Approximately $4.6 Million - GlobeNewsWire
- 9 days ago - INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform - GlobeNewsWire
- 19 days ago - INmune Bio processes first umbilical cord tissue at CGT Catapult - TheFly